Elanco Animal Health IncorporatedELANNYSE
Loading
EBITDA Over TimeContracting
Percentile Rank80
3Y CAGR-5.9%
5Y CAGR+280.9%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
-5.9%/yr
vs +18.5%/yr prior
5Y CAGR
+280.9%/yr
Recent deceleration
Acceleration
-24.3pp
Decelerating
Percentile
P80
Within normal range
vs 5Y Ago
802.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$722.00M-51.5%
2024$1.49B+764.7%
2023$-224.00M-125.9%
2022$866.00M+111.7%
2021$409.00M+45344.4%
2020$900000.00-99.8%
2019$471.60M+7.3%
2018$439.70M+412.5%
2017$85.80M-63.0%
2016$232.00M-